Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Will France's tighter medtech reimbursement rules leave industry room to manoeuvre?

This article was originally published in Clinica

Executive Summary

France is using its reimbursement system to introduce more onerous requirements than for CE marking. In the second article in Clinica's series on EU reimbursement and HTA, Dr Mark Charny, managing director of UK-based consultancy Translucency, analyses the impact of the latest challenges to having products reimbursed under increasingly stringent French rules





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts